InsaneJournal

Current mood:

gloomy

Erythromycin treatment linked to infantile hypertrophic pyloric stenosis

As referenced in: MMWR 48(49);1117-1120

Erythromycin
prophylaxis of newborns with possible experience of pertussis in a
newborn nursery was strongly connected with subsequent increased
incidence of infantile hypertrophic pyloric stenosis (IHPS) in a
Knoxville, Tennessee, hospital. The increase in IHPS was noted by
pediatric surgeons in your community and also the association established during
an investigation conducted through the CDC Division of Birth Defects and
Developmental Disabilities. The effects of the investigation are
reported in the December 17, 1999 publication of the CDC
Morbidity and Mortality Weekly Report and in the December 18,
1999 publication of the Lancet buy metacam online without a prescription. Staff inside the Division of STD Prevention, NCHSTP, CDC, reviewed the 1998
Guidelines for your Management of Sexually Transmitted Diseases to
identify tips for treatment of newborns that happen to be
potentially afflicted with the finding. The main such recommendation
is for using erythromycin to manage ophthalmia neonatorum and
infant pneumonia caused by Chlamydia trachomatis. Monitoring
in lieu of prophylactic therapy is suited to infants born to
women with C. trachomatis infection at delivery. Concern is
heightened by the lack of alternative antibiotics with established
efficacy and safety for treatment of young infants with C. trachomatis infection. The number of infants within the investigation
who developed IHPS following erythromycin was small (7), accounting
for 4. 5% of those receiving erythromycin, though the strength from the
association was strong and the timing in the exposure and recognized
actions of erythromycin about the pylorus establish biological
plausibility. Since confirmation of erythromycin like a contributor to
cases of IHPS will demand additional investigation and alternative
therapies aren't available, CDC is constantly on the recommend use of
erythromycin as described within the 1998 Guidelines for
management of C. trachomatis infections in infants. However,
readers accountable for treating such infants are strongly encouraged
to check the MMWR report. Cases of IHPS diagnosed following by using
oral erythromycin needs to be reported to the Food and Drug
Administration (FDA) as described within the MMWR report. Investigation of
other antibiotics to formulate alternatives is additionally warranted. Newer
macrolides have a lower rate of gastrointestinal side effects in
adults, but you are not FDA-approved for treatment of infants under 6
months of age, and efficacy and uncomfortable side effects compared with
erythromycin must be established before revision of current CDC
recommendations for by using erythromycin can be indicated. It must
be emphasized which the dependence on treatments for infants might be avoided by
screening women that are pregnant to detect and treat C. trachomatis
infection before delivery. buy lexapro online without prescription